Authors


Neelam Goyal, MD

Latest:

Complement Inhibitors in Myasthenia Gravis

Dr Neelam Gupta highlights differences between recently approved complement inhibitors for treatment of myasthenia gravis.


Dileep Yavagal, MD

Latest:

The Partnership Between MT2020+ and Medtronic: Dileep Yavagal, MD, and Dan Volz

The professor of clinical neurology at University of Miami and MT2020+ chair, and president of Medtronic's Neurovascular Business discussed the effort to improve global accessibility of mechanical thrombectomy.


Wayne Feng, MD, FAHA

Latest:

Expanding the Capabilities of Treating Neuromuscular Poststroke Symptoms: Wayne Feng, MD, FAHA

The division chief of stroke and vascular neurology at Duke Health provided perspective on the multidisciplinary team needed to treat neuromuscular poststroke symptoms, as well as exciting innovations on the horizon. [WATCH TIME: 4 minutes]


Yujie Wang, MD

Latest:

Rare Reactions With Natalizumab Infusion: Yujie Wang, MD

The neurologist from the University of Washington Medical Center discussed the findings of her recent study presented at ACTRIMS Forum 2021.


Lawrence Severt, MD, PhD

Latest:

Regulatory Outlook for Atogepant in Migraine: Lawrence Severt, MD, PhD

The director at AbbVie discussed the timeline for when a regulatory decision may come for migraine treatment atogepant, and whether additional trials are necessary.


Arathi Nandyala, MD

Latest:

New Treatments in Migraine: An In-Depth Review

Although new treatments and innovations are a sign of growth in migraine care, it is important to realize that growth comes with a certain amount of pain. In clinical practice, choosing the right treatment option for patients in a time-limited visit is often a dilemma.


Jacob Zwerling

Latest:

Caregiving Youth: A Call to Action for Improved Support

A systematic approach to understanding the needs of the caregiving youth—a growing and less-studied population of caregivers—is needed to better tailor interventions, provide support, and improve care to patients and their families.


Aliza Ben-Zacharia, PhD, DNP, RN, ANP-BC, FAAN

Latest:

The Importance of Localization in Addressing Misdiagnosis in Multiple Sclerosis: Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN

The assistant professor at Hunter College discussed the importance of using a systematic approach to localization and thorough consideration of clinical symptoms to enhance diagnostic accuracy and reduce misdiagnosis in multiple sclerosis. [WATCH TIME: 4 minutes]


Ammar Al-Chalabi, MB, ChB, PhD

Latest:

Ongoing Clinical Trials and the Future of ALS

Key opinion leaders review the study design and mechanisms of action for drugs in ongoing clinical trials and consider the future of amyotrophic lateral sclerosis (ALS).


Gregory W. Albers, MD

Latest:

Safely Expanding the Time Window of Thrombolysis: Gregory W. Albers, MD

The professor of neurology and director of the Stanford Stroke Center discussed the ways stroke care is evolving and the significance of the TIMELESS trial, which demonstrated the safety of tenecteplase in later-window poststroke patients. [WATCH TIME: 7 minutes]


Laura Piccio, MD, PhD

Latest:

Sustainability and Future of Intermittent Calorie Restriction in Multiple Sclerosis: Laura Piccio, MD, PhD

The neurologist and physician scientist at Washington University in St. Louis provided perspective on the need for additional studies assessing the long-term effects of dieting strategies in multiple sclerosis. [WATCH TIME: 3 minutes]


Michael Dwyer, PhD

Latest:

AI in Multiple Sclerosis: Expert Insights Into Limitations and Opportunities

Experts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.


Anuja Bandyopadhyay, MD

Latest:

The Potential and Limitations of AI Algorithms in Sleep Care: Anuja Bandyopadhyay, MD

The assistant professor of clinical pediatrics at Indiana University School of Medicine, and the chair of the AASM’s Artificial Intelligence in Sleep Medicine Committee, spoke about the ability of AI algorithms as tools in clinical care. [WATCH TIME: 3 minutes]


David Huang, MD

Latest:

Treating Trigeminal Neuralgia With Stereotactic Radiosurgery via CyberKnife: David Huang, MD

The radiation oncologist at Cooperman Barnabas Medical Center talked about how trigeminal neuralgia can be effectively treated with stereotactic radiosurgery using the CyberKnife offering pain relief without the need for invasive surgery. [WATCH TIME: 6 minutes]


Daniel Ackerman, MD, FAAN

Latest:

Addressing US Preventive Services Task Force Aspirin Recommendations for Stroke

In a time when complex medical communication to the public is on display, the need to ensure patient comprehension is of utmost importance for vascular neurologists.


Afolasade Fakolade, PhD

Latest:

Lessons from a Multiple Sclerosis Feasibility Study Focused on Movement Medicine: Afolasade Fakolade, PhD

The assistant professor at Queen’s University discussed results from a pilot trial that evaluated the impact of a dyadic physical activity intervention among both caregivers and patients with multiple sclerosis. [WATCH TIME: 3 minutes]


Erica A. Schuyler, MD

Latest:

AUPN Leadership Minute Episode 37: International Physicians in Neurology

Episode 37 of the AUPN Leadership Minute features David G. Standaert, MD, PhD, of the University of Alabama at Birmingham; and Erica A. Schuyler, MD, of the University of Connecticut. [WATCH TIME: 5 minutes]


Patricia Bobryk, MHS, MSCS, PT, ATP

Latest:

Physical Therapy Approach for Fatigue Management in Multiple Sclerosis

Fatigue, although not immediately visible, is among the most debilitating symptoms of multiple sclerosis, affecting not only patients' day-to-day functioning but their quality of life.


Stephan Züchner, MD, PhD

Latest:

The Potential of Genetic Therapies in Neuromuscular Diseases: Stephan Züchner, MD, PhD

At the 2023 MDA conference, the professor for human genetics and neurology at the University of Miami Miller School of Medicine talked about the role of genetics in neuromuscular diseases and potential therapies. [WATCH TIME: 5 minutes]


Elanda Williams, MA

Latest:

Newborn Screening Awareness Month: Understanding the Impact of Newborn Screening for SMA

Advocacy organization Cure SMA provides insight on the importance of continuing to push for standardized newborn screening and how it can positively impact outcomes in SMA.


Paul Melmeyer, MPP

Latest:

Advocacy and Progress in Rare Neuromuscular Diseases From a Policy Standpoint: Paul Melmeyer, MPP

In honor of Rare Disease Day, the vice president of public policy and advocacy at the Muscular Dystrophy Association shared his perspective of advocacy and policy progress in the realm of rare neuromuscular diseases. [WATCH TIME: 6 minutes]


Sanjeev Kothare, MD

Latest:

Sudden Unexpected Death in Epilepsy Linked With Sleep: Sanjeev Kothare, MD

The division director of pediatric neurology, and director of the pediatric sleep program at Cohen, Children's Medical Center, Northwell Health, spoke about sudden unexpected death in epilepsy and sleep at the 2022 AES Conference. [WATCH TIME: 3 minutes]


Justin Klee

Latest:

Reactions to FDA Advisory Panel Decision on AMX0035: Justin Klee; Josh Cohen, BSc

The co-CEOs and co-founders of Amylyx Pharmaceuticals discussed their immediate thoughts to the recent FDA AdComm meeting, which voted against evidence of efficacy for AMX0035 in ALS. [WATCH TIME: 3 minutes]


Yasar Torres-Yaghi, MD

Latest:

Reasons to Attend the 2023 Advanced Therapeutics in Movement & Related Disorders Congress: Fernando Pagan, MD; Yasar Torres-Yaghi, MD

The course directors of the 2023 ATRMD Congress provided an overview of the upcoming meeting, and the educational benefits clinicians can gain from attending. [WATCH TIME: 6 minutes]


Feixiong Cheng, PhD

Latest:

Understanding the Microglial Immunologic Sex Differences in Alzheimer Disease: Feixiong Cheng, PhD

The assistant professor at Cleveland Clinic discussed findings from a recently published study that provided insights on the understanding of the molecular basis for female predominance in Alzheimer disease. [WATCH TIME: 3 minutes]


Joseph R. Berger, MD

Latest:

AUPN Leading Edge Episode 4: How Much Is a Neurologist Worth? Factoring the Downstream

AUPN Leading Edge Episode 4 features Rohit Das, MD, and Joseph R. Berger, MD, who discuss how neurologists are undervalued in academic and non-academic settings when their compensation is predicated on RVUs alone. [LISTEN TIME: 26 minutes]


Virendra Mishra, PhD

Latest:

Virendra Mishra, PhD: Previous Data on Parkinson Disease Dementia

The Cleveland Clinic researcher discussed the unknowns about Parkinson disease dementia and what has been previously observed in clinical studies.


Klaus Romero, MD, MS, FCP

Latest:

Identifying Impactful Biomarkers of Alzheimer Disease: Sudhir Sivakumaran, PhD; Klaus Romero, MD, MS, FCP

The duo from the Critical Path Institute detailed the thought process behind evaluating the importance of specific biomarkers and their relation to disability progression in Alzheimer disease.


Safia Abdillahi, ACNP-BC, DNP

Latest:

Emerging Therapies in Movement Disorders and Chronic Care Management for Parkinson Disease: Safia Abdillahi, ACNP-BC, DNP

The nurse practitioner in the movement disorder division at Georgetown University Hospital discussed differences in available therapies for movement disorders versus multiple sclerosis and using a chronic care management model in Parkinson disease. [WATCH TIME: 5 minutes]


Nicholas J. Silvestri, MD, FAAN

Latest:

Fatigue and Fluctuating Symptoms in MG

Experts in neurology comment on fatigue and fluctuation of symptoms in MG and how that can contribute to a delay in diagnosis.

© 2024 MJH Life Sciences

All rights reserved.